Captor Therapeutics Spolka Akcyjna logo

Captor Therapeutics Spolka Akcyjna

WSE:CTX.WA

Overview | Financials
Company Name Captor Therapeutics Spolka Akcyjna
Symbol CTX.WA
Currency PLN
Price 105
Market Cap 487,799,550
Dividend Yield 0%
52-week-range 82 - 184
Industry Biotechnology
Sector Healthcare
CEO Dr. Thomas Shepherd Ph.D.
Website https://www.captortherapeutics.com

An error occurred while fetching data.

About Captor Therapeutics Spolka Akcyjna

Captor Therapeutics Spolka Akcyjna, a biopharmaceutical company, focuses on the discovery and development of protein degradation drugs for cancer and autoimmune diseases. The company provides Targeted Protein Degradation technology that overcomes many existing drug limitations by removing proteins resistant to available therapeutics. It has five projects at the preclinical stage.

Related Stocks

Ryvu Therapeutics S.A. logo

Ryvu Therapeutics S.A.

RVU.WA

64.5 PLN

Mercator Medical S.A. logo

Mercator Medical S.A.

MRC.WA

41.48 PLN

Mabion S.A. logo

Mabion S.A.

MAB.WA

19.28 PLN

BIOTON S.A. logo

BIOTON S.A.

BIO.WA

3.64 PLN

Celon Pharma S.A. logo

Celon Pharma S.A.

CLN.WA

15.96 PLN

Medicalgorithmics S.A. logo

Medicalgorithmics S.A.

MDG.WA

32.35 PLN

Selvita S.A. logo

Selvita S.A.

SLV.WA

59.7 PLN

NEUCA S.A. logo

NEUCA S.A.

NEU.WA

843 PLN

Financials

Numbers are in millions USD

Numbers are in millions USD